Douglas Cole

Douglas Cole

DirectoratDenali Therapeutics· In the 2023 proxy

Douglas Cole sits on 5 public boards.

Experience

  1. Denali TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -28%
  2. Sana BiotechnologyPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Foghorn TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  4. Foghorn Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Editas MedicinePublic company
    • Director? – PresentNo stock prices for these years
  6. Quanterix CorporationPublic company
    • Director? – PresentNo stock prices for these years
  7. Sigilon TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?